Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Dopamine, the kidney, and hypertension.

Harris RC, Zhang MZ.

Curr Hypertens Rep. 2012 Apr;14(2):138-43. doi: 10.1007/s11906-012-0253-z. Review.

2.

Abnormalities in renal dopamine signaling and hypertension: the role of GRK4.

Harris RC.

Curr Opin Nephrol Hypertens. 2012 Jan;21(1):61-5. doi: 10.1097/MNH.0b013e32834de2cb. Review.

3.

Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.

Jose PA, Soares-da-Silva P, Eisner GM, Felder RA.

Biochim Biophys Acta. 2010 Dec;1802(12):1259-67. doi: 10.1016/j.bbadis.2010.02.004. Review.

4.

Antihypertensive mechanisms of intra-renal dopamine.

Zhang MZ, Harris RC.

Curr Opin Nephrol Hypertens. 2015 Mar;24(2):117-22. doi: 10.1097/MNH.0000000000000104. Review.

5.

Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity.

Felder RA, Jose PA.

Nat Clin Pract Nephrol. 2006 Nov;2(11):637-50.

PMID:
17066056
7.

Human GRK4γ142V Variant Promotes Angiotensin II Type I Receptor-Mediated Hypertension via Renal Histone Deacetylase Type 1 Inhibition.

Wang Z, Zeng C, Villar VA, Chen SY, Konkalmatt P, Wang X, Asico LD, Jones JE, Yang Y, Sanada H, Felder RA, Eisner GM, Weir MR, Armando I, Jose PA.

Hypertension. 2016 Feb;67(2):325-34. doi: 10.1161/HYPERTENSIONAHA.115.05962.

PMID:
26667412
8.

A novel role for c-Myc in G protein-coupled receptor kinase 4 (GRK4) transcriptional regulation in human kidney proximal tubule cells.

Gildea JJ, Tran HT, Van Sciver RE, Bigler Wang D, Carlson JM, Felder RA.

Hypertension. 2013 May;61(5):1021-7. doi: 10.1161/HYPERTENSIONAHA.111.00321.

9.

Dopamine and the kidney: a role in hypertension?

Jose PA, Eisner GM, Felder RA.

Curr Opin Nephrol Hypertens. 2003 Mar;12(2):189-94. Review.

PMID:
12589180
10.

Role of GRK4 in the regulation of arterial AT1 receptor in hypertension.

Chen K, Fu C, Chen C, Liu L, Ren H, Han Y, Yang J, He D, Zhou L, Yang Z, Zhang L, Jose PA, Zeng C.

Hypertension. 2014 Feb;63(2):289-96. doi: 10.1161/HYPERTENSIONAHA.113.01766.

11.

Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats.

Yatabe J, Sanada H, Midorikawa S, Hashimoto S, Watanabe T, Andrews PM, Armando I, Wang X, Felder RA, Jose PA.

Hypertens Res. 2008 Jul;31(7):1455-64. doi: 10.1291/hypres.31.1455.

12.

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Watanabe T, Moore JH, Ritchie MD, Williams SM, Pezzullo JC, Sasaki M, Eisner GM, Jose PA, Felder RA.

Clin Chem. 2006 Mar;52(3):352-60.

13.

Functional genomics of the dopaminergic system in hypertension.

Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA.

Physiol Genomics. 2004 Nov 17;19(3):233-46. Review.

14.

Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression.

Sanada H, Yatabe J, Midorikawa S, Katoh T, Hashimoto S, Watanabe T, Xu J, Luo Y, Wang X, Zeng C, Armando I, Felder RA, Jose PA.

Hypertension. 2006 Jun;47(6):1131-9.

15.

G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor.

Villar VA, Jones JE, Armando I, Palmes-Saloma C, Yu P, Pascua AM, Keever L, Arnaldo FB, Wang Z, Luo Y, Felder RA, Jose PA.

J Biol Chem. 2009 Aug 7;284(32):21425-34. doi: 10.1074/jbc.M109.003665.

16.

The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.

Armando I, Konkalmatt P, Felder RA, Jose PA.

Transl Res. 2015 Apr;165(4):505-11. doi: 10.1016/j.trsl.2014.07.006. Review.

17.

Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.

Chen K, Deng K, Wang X, Wang Z, Zheng S, Ren H, He D, Han Y, Asico LD, Jose PA, Zeng C.

Hypertension. 2015 Jan;65(1):153-60. doi: 10.1161/HYPERTENSIONAHA.114.04038.

18.

[G protein kinase 4gammaA142V overexpression induced hypertension by downregulating D1 receptors in transgenic mice].

Zeng CY, Wang Z, Yang ZW, He DF, Yang CM, Asico LD, Felder RA, Jose PA.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 May;34(5):411-4. Chinese.

PMID:
16776954
19.

Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4.

Allen SJ, Parthasarathy G, Darke PL, Diehl RE, Ford RE, Hall DL, Johnson SA, Reid JC, Rickert KW, Shipman JM, Soisson SM, Zuck P, Munshi SK, Lumb KJ.

J Biol Chem. 2015 Aug 14;290(33):20360-73. doi: 10.1074/jbc.M115.648907.

20.

Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.

Yoshida S, Ishizawa K, Ayuzawa N, Ueda K, Takeuchi M, Kawarazaki W, Fujita T, Nagase M.

Clin Exp Nephrol. 2014 Aug;18(4):593-9. doi: 10.1007/s10157-013-0893-6.

PMID:
24154707
Items per page

Supplemental Content

Support Center